Intel Skyrocketed 30% Higher in 1 Month: Here’s What to Do Now
Intel has surged past its average analyst price target after one of its biggest monthly runs in years, and now bulls and bears are locked in a standoff over whether the turnaround still has teeth or the easy money is…
At $123.86, Intel (NASDAQ:INTC | INTC Price Prediction) looks fully priced. The chipmaker has ripped 37.52% higher in the past month and now trades above the average Wall Street price target, which forces a hard question about whether the turnaround story still has room to run.
Intel is the largest U.S.-based logic chip manufacturer, spanning client PCs, data center CPUs, and a contract foundry competing with TSMC and Samsung. CEO Lip-Bu Tan is pushing the 18A process into volume, securing a NVIDIA (NASDAQ:NVDA) $5 billion NVIDIA equity stake and U.S. government backing, while posting genuine data center growth. Meta (NASDAQ:META) drove a broad CPU rally as Meta’s Muse AI agent triggered a broad CPU rally, lifting Intel double digits in a single session this week.
Why Bulls Believe the Comeback Is Real
Q2 fiscal 2026 gave bulls hard numbers. Revenue reached $16.13 billion, up 25.42% year over year, described as the strongest revenue growth in more than 15 years. Data Center and AI revenue jumped 59%, non-GAAP EPS of $0.42 nearly doubled the $0.2175 consensus, and operating cash flow hit $7 billion.
Forward estimates are climbing fast. The 2027 fiscal-year EPS consensus has risen from $1.5236 ninety days ago to $2.0621, with 30 upward EPS revisions against zero downward revisions in the trailing 30 days. Xeon 6 is ramping as one of the fastest products in Intel history, and NVIDIA selected Xeon 6 for DGX Rubin NVL8 systems, supporting a credible path to a $2-plus EPS run rate.
Why Bears See a Crowded Long
Valuation has moved faster than fundamentals. Intel carries a Forward P/E of 57, a price-to-sales ratio of 11, and an EV/EBITDA of 162. Trailing EPS is -$2.09. Intel Foundry posted a $2.1 billion Q2 operating loss on just $293 million of external foundry revenue.
CFO David Zinsner warned that supply “will not catch up” in the fourth quarter. Management expects PC consumption down low double digits for all of 2026 and capex rising to more than $20 billion in 2026, with 2027 significantly higher. CEO Lip-Bu Tan sold shares into the rally, per recent Form 4 filings.
Why Patience May Be the Sharper Trade
The story is directionally right, but the price reflects much of it already. Intel is executing on 18A, but external foundry revenue remains minimal and 14A customer commitments are unnamed. Watch Q3 results against guidance of $15.8B to $16.8B in revenue and $0.38 non-GAAP EPS, foundry loss trajectory, and any named 14A customer.
Where the Numbers Land Right Now
Intel trades at $123.86 against a mean analyst target of $116.37, implying roughly 6% downside. Coverage spans 48 analysts: 1 Strong Buy, 13 Buy, 32 Hold, 1 Sell, and 1 Strong Sell. The Hold-heavy distribution reflects the same tension the price does.
Intel is up 37.52% in the past month and 235.66% year to date, versus the S&P 500’s 1.01% monthly gain and 13.42% year to date. Shares sit closer to the 52-week high of $142.35 than to the 50-day moving average of $97.09, with a Beta of 2.231.
Why the Setup Argues for Patience at This Price
At $123.86, Intel looks fully valued. Here is why.
The fundamental story justifies a re-rating, but the stock has front-run the operational proof. Bulls need external foundry commitments, sustained DCAI share gains, and shrinking foundry losses to defend a Forward P/E in the fifties. Bears need a Q4 disappointment or margin squeeze to break momentum. Both camps still lack decisive evidence.
Bullish catalysts to watch: a named Intel 14A external customer with wafer commitments, foundry operating loss below $1.5 billion per quarter, or a pullback toward $97. Bearish catalysts to watch: a Q3 miss versus the $16.3 billion midpoint, stalling Panther Lake yields, or capex forcing equity issuance.
The cost of patience is missing the next leg higher if 14A customer news hits. The cost of buying here is paying peak-optimism prices for a business still generating negative trailing EPS and a foundry losing $2 billion a quarter. Buying a stock at fresh highs is a legitimate move if the entry, sizing, and stops are disciplined (we put ten rules for doing it safely in a free breakout buyer’s guide here). When the analyst mean target sits below the current price after a 37% one-month move, the clear read is that the easy money has been made and the next data points will decide the trade.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
